deltatrials
Unknown OBSERVATIONAL NCT05473884

Lesion Preparation in Femoropopliteal Artery Occlusion Disease (CIVILIAN)

CIVILIAN Study in Femoropopliteal Artery Occlusion Disease

Sponsor: First Affiliated Hospital of Zhejiang University

Updated 6 times since 2022 Last updated: Nov 2, 2022 Started: Jun 1, 2022 Primary completion: May 31, 2024 Completion: May 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Atherosclerosis Obliterans and Femoropopliteal Artery Occlusion and is currently ongoing. First Affiliated Hospital of Zhejiang University leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshotRecruiting~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshotRecruiting~Dec 2022 – ~Jul 2024 · 19 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshotRecruiting~Dec 2024 – present · 21 months · monthly snapshotUnknown

Change History

6 versions recorded
  1. Dec 2024 — Present [monthly]

    Unknown

    Status: RecruitingUnknown

  2. Sep 2024 — Dec 2024 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Dec 2022 — Jul 2024 [monthly]

    Recruiting

  5. Nov 2022 — Dec 2022 [monthly]

    Recruiting

    Phase: NANone

Show 1 earlier version
  1. Sep 2022 — Nov 2022 [monthly]

    Recruiting NA

    First recorded

Jun 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • First Affiliated Hospital of Zhejiang University
  • Huashan Hospital
  • Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
  • Qingdao Hiser Medical Group
  • RenJi Hospital
  • Second Affiliated Hospital of Soochow University
  • Shanghai Pudong Hospital
  • Shanghai Zhongshan Hospital
  • Xuanwu Hospital, Beijing
Data source: Shanghai Pudong Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations